Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Santos Enrech-Frances"'
Autor:
José Miguel Martín Martínez, Teresa Molina-Garcia, Laura López-Esteban, Rocío Vázquez-Sánchez, Miguel Soria-Tristán, Laura Díaz-Paniagua, Ana Sanchez-Pena, Raúl Diez-Fernández, Santos Enrech-Frances
Publikováno v:
Journal of Oncology Pharmacy Practice. 24:511-516
Purpose Ethanol as an excipient is used to enhance the solubility of gemcitabine, but, sometimes, the dose of ethanol a patient may be given is much higher than the dose considered to be toxic. We aimed to assess ethanol-related symptoms and signs in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d6d40815898ae2db26751fb9f00738
https://doi.org/10.1177/1078155217715790
https://doi.org/10.1177/1078155217715790
Autor:
Thomas Bachelot, Alberto Ballestrero, Marco Colleoni, José Valero Alvarez, Amer Sami, Celalettin Camci, Rodrigo Lastra del Prado, Luis De La Cruz Merino, Antonio Bernardo, Peter Barrett-Lee, Yolanda Fernández Pérez, Vladimir Semiglazov, Thierry Petit, Mette Holck Nielsen, C. Langridge, Guillermo López Vivanco, Nik Hauser, Ignacio Porras Quintela, José Manuel Pérez García, Anna-Karin Wennstig, Victoria Dvornichenko, Erik Jakobsen, Guzel Mukhametshina, Heiko Graf, V. Jenkins, Mireille Mousseau, Alfonso Sanchez Muñoz, Pehr Lind, Irina Bulavina, Alexey Manikhas, Bengt Norberg, Xavier Pivot, Per Edlund, Sandeep Sehdev, Valerie Jenkins, Santos Enrech Frances, Nadia Califaretti, V. Müller, G. Curigliano, Duncan Wheatley, Stephen L. Chan, Enrique Espinosa Arranz, S. Osborne, Soeren Linnet, Nana Scotto, J. Gligorov, Volkmar Müller, Tjoung-Won Park-Simon, Karen McAdam, Ann Knoop, Giuseppe Curigliano, X. Pivot, Justine Kilkerr, Georg Heinrich, L. Fallowfield, Francisco Carabantes Ocon, Christopher Wolf, Robert El-Maraghi, Hugues Bourgeois, Christelle Levy, Luca Gianni, Russell Burcombe, Vadim Shirinkin, Huseyin Abali, Etienne Brain, Christoph Tausch, Lidia Perlova-Griff, Claudia Plesse Lefeuvre, Joseph Gligorov, Mikhail Lichinitser, Friedrich Overkamp, S. Verma, Kathryn Monson, Angela Stefania Ribecco, Doris Augustin, Lesley Fallowfield, Saad Tahir, Javier Cassinello Espinosa, Marcus Schmidt, Jacek Jassem, Laurent Zelek, Ruchan Uslu, Richard Simcock, Sherko Kuemmel, Javier Salvador Bofill, A. Knoop, Hervé Bonnefoi, Fikret Arpaci, Silvana Spadafora, Sunil Verma, Hendrik Kroening, Elżbieta Brewczynska
Publikováno v:
Annals of Oncology. 25:1979-1987
Patients with HER2-positive early breast cancer (EBC) preferred subcutaneous (s.c.) trastuzumab, delivered via single-use injection device (SID), over the intravenous (i.v.) formulation (Cohort 1 of the PrefHer study: NCT01401166). Here, we report pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b145cdce1456ae985a553171af8850a2
https://doi.org/10.1093/annonc/mdu364
https://doi.org/10.1093/annonc/mdu364
Autor:
Ana Sanchez-Pena, Teresa Molina-Garcia, Rocío Vázquez-Sánchez, Santos Enrech-Frances, Raúl Diez-Fernández
Publikováno v:
International journal of clinical pharmacy. 38(4)
Background The combination of cisplatin or carboplatin with vinorelbine is one of the standard regimens in non-small-cell lung cancer. Some studies have shown that the hemogram on day-8 could be avoided in patients with cisplatin. However, carboplati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652186cd3136175b0d79981232b7ce34
https://pubmed.ncbi.nlm.nih.gov/27164956
https://pubmed.ncbi.nlm.nih.gov/27164956
Autor:
Teresa Molina-Garcia, Ana Sanchez-Pena, Raúl Diez-Fernández, Rocío Vázquez Sánchez, Santos Enrech-Frances
Publikováno v:
Journal of Clinical Oncology. 33:e17749-e17749
e17749 Background: The combination of platinum drugs (carboplatin, cisplatin), given on day 1, and vinorelbine, given on days 1 and 8, every 3 weeks is one of the standard regimens in several cance...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8f687f105c260fe7b5bb00940f18fce
https://doi.org/10.1200/jco.2015.33.15_suppl.e17749
https://doi.org/10.1200/jco.2015.33.15_suppl.e17749
Autor:
Jimena Ramon Garcia, Santos Enrech-Frances, Teresa Molina García, Pedro Rodriguez Quesada, Raul Diez-Fernandez
Publikováno v:
Journal of Clinical Oncology. 32:1057-1057
1057 Background: Paclitaxel is one of the standard adjuvant treatments in localized breast cancer. Weekly paclitaxel has shown to improve disease-free and overall survival compared to every three w...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::386d304c4458e7acad01f1fa314b0fb1
https://doi.org/10.1200/jco.2014.32.15_suppl.1057
https://doi.org/10.1200/jco.2014.32.15_suppl.1057